Management ChangeOct 6, 2026, 04:36 PM
Quest Diagnostics EVP Catherine Doherty to Retire in July 2027
AI Summary
Quest Diagnostics Incorporated announced that Catherine T. Doherty will retire in July 2027. Until her retirement, Ms. Doherty will transition to a new role as Executive Vice President, effective November 1, 2026. In this new capacity, she will oversee health systems, the company's joint venture with Corewell Health, and Project Nova, a multi-year initiative to modernize business processes. Her compensation, including base salary and incentive targets, will remain unchanged. Additionally, she will receive an equity award valued at $1,200,000, primarily in restricted stock units.
Key Highlights
- Catherine T. Doherty to retire in July 2027.
- Effective November 1, 2026, Ms. Doherty transitions to Executive Vice President role.
- New role includes responsibilities for health systems, joint venture with Corewell Health, and Project Nova.
- No change to Ms. Doherty's annual base salary of $650,000.
- No change to annual incentive compensation target of 80% of base salary.
- Approved equity award with a target value of $1,200,000, allocated 100% to restricted stock units.
Price Impact
More from DGX
More in Management Change